Richard Sykes is currently Chairman of Imperial College Healthcare NHS Trust, the Royal Institution of Great Britain, the UK Stem Cell Foundation, OmniCyte, NetScientific and PDS Biotechnology Corporation. In 2013, he was appointed Chancellor of Brunel University, prior to which he served as Rector of Imperial College London from 2000–2008.
He was Non-executive Director of Rio Tinto from 1997–2007, and has over 30 years’ experience within the biotechnology and pharmaceutical industries field — serving as Chief Executive and Chairman of GlaxoWellcome from 1995–2000, then Chairman of GlaxoSmithKline until 2002.
Internationally, Richard is Chairman of the International Advisory Board of the A*STAR Biomedical Research Council, Singapore, and was awarded Honorary Citizenship of Singapore in 2004 for his contribution to the development of the country’s biomedical sciences industry. He holds a number of honorary degrees and is Fellow or Honorary Fellow of many learned societies and academic institutions, including King’s College London and the universities of Wales and Central Lancashire. He received a knighthood in 1994 for services to the pharmaceutical industry.
Chairman, Royal Institution Of Great Britain
Chairman, UK Stem Cell Foundation
Chairman, Imperial College Healthcare NHS Trust
Chairman, NetScientific plc
Chairman, PDS Biotechnology Corporation
Interest and expertise
- Microbiology, immunology and developmental biology
- General microbiology (incl bacteriology and virology)
Antibiotics, B-lactamases, Antibiotic Resistance